EWG Elevate’s Prestige Consumer Healthcare PBH Stock Holding History

EWG Elevate’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-70	Closed	-$4.38K	–	561
2022 Q4	$4.38K	Buy	+70	New	+$4.01K	﹤0.01%	485

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EWG Elevate's PBH Position: Q1 2023 in Review

EWG Elevate sold out of Prestige Consumer Healthcare (PBH) in Q1 2023, closing a stake of 70 shares — an estimated $4.38K sold.

EWG Elevate first reported a position in PBH in Q4 2022 and held it in 1 quarter. The position peaked at $4.38K in Q4 2022. 283 funds tracked by Wall St. Rank hold PBH as of Q1 2023.

EWG Elevate reported no remaining Prestige Consumer Healthcare position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 70 Prestige Consumer Healthcare shares in Q1 2023, an estimated $4.38K.
EWG Elevate first reported a position in Prestige Consumer Healthcare in Q4 2022 and held it in 1 quarter.
EWG Elevate's Prestige Consumer Healthcare position peaked at $4.38K in Q4 2022.
283 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.